Author:
Rodrigues Angélica Nogueira,de Melo Andréia Cristina,Calabrich Aknar Freire de Carvalho,Cronenberger Eduardo,Torres Kátia Luz,Damian Fernanda,Cossetti Rachel,de Azevedo Carla Rameri Alexandre Silva,da Fonseca Allex Jardim,Nerón Yeni,Nunes João,Lopes André,Thomé Felipe,Leal Renato,Borges Giuliano,da Silva Arthur Ferreira,Rodrigues Matheus Füehr,Nunes Filho Paulo Ricardo Santos,Zaffaroni Facundo,Freitas Raquel Dal Sasso,Werutsky Gustavo,Maluf Fernando
Abstract
ObjectivesCervical cancer is the fourth most common cancer in women worldwide. Epidemiological and quality of life (QoL) data in patients with cervical cancer from low- and middle-income countries are scarce. We aimed to describe sociodemographic and clinicopathological characteristics and quality of life of patients with cervical cancer at diagnosis in Brazil.MethodsEVITA is a prospective cohort study of newly diagnosed patients with cervical cancer from May 2016 to December 2017, stages I–IVB, from 16 Brazilian sites representing the five Brazilian regions. At baseline, medical evaluation was performed and European Organization for Research and Treatment of Cancer (EORTC) QLQ-CX24/C30 questionnaires were administered.ResultsA total of 631 patients were included. Mean±SD age was 49.3±13.9 years; skin color was non-white in 65.3%, and 68.0% had ≤8 years of formal education. In total, 85.1% of patients had a Pap smear. The main reasons reported by patients for not having a Pap smear were: lack of interest (46.9%), shame or embarrassment (19.7%), lack of knowledge (19.7%), and difficulty with access (9.1%). Most patients were diagnosed with locally advanced or metastatic disease (FIGO clinical stage II–IV in 81.8%– stage II in 35.2%, stage III in 36.1%, and stage IV in 10.5%). Patients with clinical stage III–IV had worse physical functioning and role functioning.ConclusionsCervical cancer in Brazil is usually diagnosed at an advanced stage. Most patients have low formal education and are unemployed. Lack of interest was identified as a main reason for not having a screening test, and limited access was reported as a reason by <10% of the patients. Awareness campaigns must be a governmental priority, specially focused on the needy population, along with wide access to treatment.
Subject
Obstetrics and Gynecology,Oncology
Reference21 articles.
1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2. Institute for Health Metrics and Evaluation (IHME) . GBD compare, 2020. Available: https://vizhub.healthdata.org/gbd-compare/ [Accessed 10 Oct 2021].
3. Instituto Nacional de Câncer José Alencar Gomez da Silva . Estimativa 2020 : incidência de câncer no Brasil, 2020. Available: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//estimativa-2020-incidencia-de-cancer-no-brasil.pdf [Accessed 12 Apr 2021].
4. INCA . Atlas On-line de Mortalidade. Available: https://www.inca.gov.br/MortalidadeWeb/pages/Modelo03/consultar.xhtml#panelResultado [Accessed 14 Jul 2021].
5. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries;Canfell;Lancet,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献